Literature DB >> 4758790

Animal model of human disease. Primary amebic meningoencephalitis, Naegleria meningoencephalitis, CNS protozoal infection.

A J Martinez, E C Nelson, R J Duma.   

Abstract

Entities:  

Mesh:

Year:  1973        PMID: 4758790      PMCID: PMC1904066     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  7 in total

1.  Acanthamoeba: observations on animal pathogenicity.

Authors:  C G CULBERTSON; J W SMITH; J R MINNER
Journal:  Science       Date:  1958-06-27       Impact factor: 47.728

Review 2.  Primary amoebic meningoencephalitis.

Authors:  R J Duma
Journal:  CRC Crit Rev Clin Lab Sci       Date:  1972-06

Review 3.  Primary amoebic meningo-encephalitis. An appraisal of present knowledge.

Authors:  R F Carter
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

4.  Experimental Naegleria meningoencephalitis in mice. An electron microscope study.

Authors:  A J Martinez; E C Nelson; M M Jones; R J Duma; W I Rosenblum
Journal:  Lab Invest       Date:  1971-11       Impact factor: 5.662

5.  Acute pyogenic meningitis probably due to Acanthamoeba sp.: a preliminary report.

Authors:  M Fowler; R F Carter
Journal:  Br Med J       Date:  1965-09-25

6.  Primary amoebic meningoencephalitis caused by Naegleria. Two new cases, response to amphotericin B, and a review.

Authors:  R J Duma; W I Rosenblum; R F McGehee; M M Jones; E C Nelson
Journal:  Ann Intern Med       Date:  1971-06       Impact factor: 25.391

7.  The pathogenicity of soil amebas.

Authors:  C G Culbertson
Journal:  Annu Rev Microbiol       Date:  1971       Impact factor: 15.500

  7 in total
  10 in total

1.  Immunization of mice against Naegleria fowleri infection.

Authors:  D T John; R R Weik; A C Adams
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

Review 2.  Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion.

Authors:  Samantha J Dando; Alan Mackay-Sim; Robert Norton; Bart J Currie; James A St John; Jenny A K Ekberg; Michael Batzloff; Glen C Ulett; Ifor R Beacham
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

3.  Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.

Authors:  Shannon M Soltow; George M Brenner
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

4.  Bis-benzimidazole hits against Naegleria fowleri discovered with new high-throughput screens.

Authors:  Christopher A Rice; Beatrice L Colon; Mehmet Alp; Hakan Göker; David W Boykin; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

5.  Phenothiazine compounds inhibit in vitro growth of pathogenic free-living amoebae.

Authors:  F L Schuster; N Mandel
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

6.  Host resistance of mice to Naegleria fowleri infections.

Authors:  M F Reilly; K L White; S G Bradley
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

7.  In vitro susceptibility of pathogenic Naegleria and Acanthamoeba speicies to a variety of therapeutic agents.

Authors:  R J Duma; R Finley
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

8.  Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.

Authors:  Shannon M Goswick; George M Brenner
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

9.  Cytopathogenicity of Naegleria fowleri in mammalian cell cultures.

Authors:  D T John; R A John
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

10.  Iron-Binding Protein Degradation by Cysteine Proteases of Naegleria fowleri.

Authors:  Moisés Martínez-Castillo; Gerardo Ramírez-Rico; Jesús Serrano-Luna; Mineko Shibayama
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.